in | |||||
NEWS | |||||
AstraZeneca to buy Alexion in $39bn immunology deal Anglo-Swedish drugmaker AstraZeneca has agreed to buy US biotechnology group Alexion in a $39bn deal, marking the biggest agreement struck by ...
| |||||
Fiat Chrysler's Manley in pole position for Ferrari CEO job, paper says Camilleri is recovering at home from COVID-19 after a spell in hospital. Ferrari and FCA Chairman John Elkann, the scion of Italy's Agnelli family, is ...
| |||||
AS IT HAPPENED - Third Practice in Abu Dhabi Hamilton does slightly better but he can't match the Red Bull either - a 1m 37.012s for the world champion leaves him 0.278s adrift in second, ...
| |||||
Pakistan accuses India of funding disinformation campaign in EU In making its claim that India attempted to manipulate international bodies through fake news websites and organisations, Pakistan's foreign minister ...
| |||||
How to Build Trust in the Vaccines This week is coming to a close with truly miraculous news: In the coming days, Americans across the country are expected to begin getting vaccinated ...
| |||||
Containing Covid-19 Helped Boost These Stock Markets in 2020 Shares in New Zealand, Japan, Taiwan, South Korea and Finland –- the top five spots in Bloomberg's Covid Resilience Ranking -- have climbed 15% on ...
| |||||
As Germany awaits vaccine, mass vaccination centers are built in less than a week Albrecht Broemmer is in charge of getting six in Berlin ready, and it's tight. "That's my duty, but it's hard work to get to it," he said. The string ...
| |||||
Austrian Constitutional Court overturns headscarf ban in schools Austria's Constitutional Court has ruled that a law banning girls aged up to 10 from wearing headscarves in schools was discriminatory, overturning ...
| |||||
'A little person in history': the adolescents who signed up to test the COVID vaccine NEW YORK, Dec 11 (Reuters) - Two adolescent siblings in the United States who signed up for a coronavirus vaccine trial said they did it because ...
| |||||
Sanofi suffers major setback in development of a Covid-19 vaccine The news is not just disappointing for Sanofi and its development partner, GlaxoSmithKline, which is providing an adjuvant used in the vaccine.
| |||||
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment